HomeCare Guidelines
Care Guidelines
Care Guidelines
Duchenne Muscular Dystrophy Speech Delay: Understanding Language Development in Children with DMD
Duchenne muscular dystrophy speech delay is an important developmental concern that families and healthcare professionals should recognize. Although Duchenne muscular dystrophy (DMD) is primarily known as a genetic neuromuscular condition causing progressive muscle weakness, research has shown that some boys with DMD can also experience differences or delays in...
Care Guidelines
Guide to DMD for Parents and Teachers at School: A Complete Guide for Safety, Learning, Friendship and Inclusion
A well-structured guide to DMD for parents and teachers at school is essential for supporting children with Duchenne Muscular Dystrophy (DMD) in educational environments. DMD is a progressive neuromuscular condition that affects muscle strength, endurance, and sometimes cognitive functioning. These challenges directly influence how a child participates in school...
Keep exploring
Care Guidelines
Better Night’s Sleep with BiPAP Machine: A Complete Guide for DMD Patients and Caregivers
Living with Duchenne muscular dystrophy (DMD) comes with many daily challenges, and breathing difficulties...
Care Guidelines
Multidisciplinary Neuromuscular Team in Duchenne Muscular Dystrophy (DMD): Roles and Benefits
Duchenne muscular dystrophy (DMD) is a progressive, genetic neuromuscular disorder that affects muscle strength,...
Care Guidelines
What Are the Pros and Cons of Steroids (Cortisone) for Duchenne Muscular Dystrophy (DMD)?
Duchenne Muscular Dystrophy (DMD) is a progressive genetic disorder that causes muscle weakness and...
Care Guidelines
When Is The Best Time for a Power Wheelchair in DMD?
For families navigating a diagnosis of Duchenne muscular dystrophy (DMD), mobility changes are a...
Care Guidelines
How Does Duchenne Affect Dental Health? A Comprehensive Guide for Parents and Caregivers
Duchenne muscular dystrophy (DMD) is a progressive genetic disorder that primarily affects muscle strength...
Care Guidelines
What is Rhabdomyolysis in Duchenne Muscular Dystrophy: Symptoms, Causes, Treatment
Rhabdomyolysis is a serious medical condition involving the rapid breakdown of muscle tissue, leading...
Care Guidelines
Ankle Foot Orthosis (AFO) in Duchenne Muscular Dystrophy (DMD): Benefits, Uses, and Care Tips
Ankle Foot Orthosis (AFO) devices are pivotal in assisting individuals with Duchenne Muscular Dystrophy...
Care Guidelines
What Duchenne Muscular Dystrophy (DMD) Patients Who Need to Have Surgery Under Anesthesia Should Know
While medical advancements have significantly improved the quality of life for DMD patients, surgical...
Care Guidelines
Glucocorticoid Use in DMD Patients and Impact on Growth Effect
A childhood hereditary disorder known as Duchenne muscular dystrophy (DMD) is characterized by increasing...
Latest articles
Press Releases
Entrada Therapeutics ENTR-601-45: Early Exon 45 Skipping Study Shows Increased Dystrophin Production
Entrada Therapeutics has announced positive initial results from its Exon 45 Skipping Study, ELEVATE-45-201,...
Press Releases
Entrada Therapeutics Advances ENTR-601-44 to 18 mg/kg in Its Duchenne Exon 44 Skipping Study
Entrada Therapeutics has received clearance to test the highest dose in its Exon 44...
Research
Sapreme Therapeutics Reports Strong Preclinical Dystrophin Restoration With SPM-2551 in Duchenne
Sapreme Therapeutics has announced promising preclinical results for SPM-2551, an experimental treatment for Duchenne...
Press Releases
Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne
Capricor Therapeutics has reported new results from the HOPE-3 study evaluating Deramiocel in people...
Press Releases
Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne
Ractigen Therapeutics has presented positive first-in-human data for RAG-18 (NCT07282652), an investigational treatment for...
Press Releases
Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data
Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for patients with Duchenne muscular dystrophy...
Press Releases
NS Pharma’s Brogidirsen Shows 5-Year Clinical Data in DMD Patients Amenable to Exon 44 Skipping
NS Pharma’s brogidirsen (NS-089/NCNP-02) is an investigational therapy for Duchenne muscular dystrophy (DMD) designed...
Press Releases
ELEVIDYS WMS 2026 Data: What They Show—and What They Don’t
Sarepta Therapeutics has presented new data on ELEVIDYS (delandistrogene moxeparvovec) at the 2026 World...
